58results about How to "Affecting its function" patented technology

A Radio Frequency Identification (RFID) system for managing and identifying locations for an RFID reader is disclosed. An expected location of a fixed radio frequency identification (RFID) reader is determined. A first signal is transmitted from the reader to a first RFID tag to determine whether the reader is at the expected location. The first tag is a fiducial RFID tag fixed at a first location. In one aspect, the reader receives a first response to the first signal from the first tag. The first response identifies the first location of the first tag. The first location is compared to the expected location. If the first location and the expected location are different, an alarm is triggered.

A method of modifying surfaces of a device, for example, a medical device, is disclosed. The method includes modifying a surface of a device by providing a device, exposing the device to a reactive gas and plasma energy to create a plasma deposited surface on the device, and quenching the device with the reactive gas. The device exhibits changes in its surface properties thereby making it more desirable for an intended use.< / PTEXT>

Provided herein are compositions, reactions mixtures, mutant Ras proteins, kits, substrates, and systems for selecting a Ras antagonist, as well as methods of using the same.

A method of modifying surfaces of a device, for example, a medical device, is disclosed. The method includes modifying a surface of a device by providing a device, exposing the device to a reactive gas and plasma energy to create a plasma deposited surface on the device, and quenching the device with the reactive gas. The device exhibits changes in its surface properties thereby making it more desirable for an intended use.

Provided herein are compositions, reactions mixtures, mutant Ras proteins, kits, substrates, and systems for selecting a Ras antagonist, as well as methods of using the same.

A noise-reduction microphone, a noise-reduction safe earphone and a noise-reduction safe Bluetooth headset, comprising an acoustic wave concentrator which has a sound signal capturing unit at its big end used to capture sound wave signal and amplify the external sound wave signal, and then transmitted to the small end of the acoustic wave concentrator connected to the air tube, and the air tube is connected to the receiver device which receives the acoustic signal from the air tube and converts it into electrical sound signals transmitted to a voice terminal from the receiver device by a connector. The sound information is transmitted by the air tube, so the length of the air to be could be setted pretty long so that people can keep at a distance from electrical equipments with radiation, the remote air tube microphone can be separately used as microphone or mike.

The invention provides therapeutic and prophylactic compounds and methods for altering the activity of pyruvate dehydrogenase kinase (e.g. PDK1, PDK2, PDK3, PDK4). Such therapies are useful for the treatment of neoplasia. The invention further provides therapeutic and prophylactic compounds and methods of altering pyruvate dehydrogenase activity to treat or prevent cell death related to ischemia.

The present invention provides wood preservative compositions comprising micronized particles. In one embodiment, the composition comprises dispersions of micronized metal or metal compounds. In another embodiment, the wood preservative composition comprises an inorganic biocide comprising a metal or metal compound and organic biocide. When the composition comprises an inorganic biocide and an organic biocide, the inorganic biocide or the organic biocide or both are present as micronized particles. When compositions of the present invention are used for preservation of wood, there is minimal leaching of the metal and biocide from the wood.

The application describes small molecules capable of modulating activity of beta2 family of integrins, such as integrin CD11b / CD18 (also known as Mac-1, CR3 and αMβ2). Such compounds may be used in certain embodiments for treating a disease or condition, such as inflammation, immune-related disorders, cancer, ischemia-reperfusion injury, stroke, neointimal thickening associated with vascular injury, wound-healing, organ transplantation and cardiovascular disease, among others.

The invention relates to a method for altering the conformational diversity of a first repertoire of polypeptide ligands, comprising a plurality of polypeptides comprising at least two reactive groups separated by a loop sequence covalently linked to a molecular scaffold which forms covalent bonds with said reactive groups, to produce a second repertoire of polypeptide ligands, comprising assembling said second repertoire from the polypeptides and structural scaffold of said first repertoire, incorporating one of the following alterations: (a) altering at least one reactive group; or (b) altering the nature of the molecular scaffold; or (c) altering the bond between at least one reactive group and the molecular scaffold; or (d) any combination of (a), (b) or (c).

A module for an aircraft having a fuselage structure and a floor element defining a floor plane. The module includes a frame device adapted for mounting a functional element and the frame device is adapted for attachment to the floor element of the aircraft at a first location in the floor plane. The frame device is adapted for attachment to the fuselage structure of the aircraft at a second location, wherein the second location is not in the floor plane.

As described below, the present invention features compositions and methods related to the isolation, culture and therapeutic use of CD31-expressing cells.

The invention relates to a method for altering the conformational diversity of a first repertoire of polypeptide ligands, comprising a plurality of polypeptides comprising at least two reactive groups separated by a loop sequence covalently linked to a molecular scaffold which forms covalent bonds with said reactive groups, to produce a second repertoire of polypeptide ligands, comprising assembling said second repertoire from the polypeptides and structural scaffold of said first repertoire, incorporating one of the following alterations: (a) altering at least one reactive group; or (b) altering the nature of the molecular scaffold; or (c) altering the bond between at least one reactive group and the molecular scaffold; or (d) any combination of (a), (b) or (c).

An inlet port provides a fluid entrance to a body. A chamber has an inner surface. An outlet port is in fluid communication with the chamber and provides a fluid exit from the body. The piston is moveable within the chamber between a first set position, in which the inlet port is not in fluid communication with the outlet port, and a second open position, in which the inlet port is in fluid communication with the outlet port through the chamber. A seal guard is slidably disposed within the chamber. The seal guard is moveable between a first seal-guard position and a second seal-guard position in which the seal guard shields the seal. The seal guard is in the first seal-guard position when the piston is in its first set position and in the second seal-guard position when the piston is in its second open position.

Improvements on the basic method used for BEAMing increase sensitivity and increase the signal-to-noise ratio. The improvements have permitted the determination of intrinsic error rates of various DNA polymerases and have permitted the detection of rare and subtle mutations in DNA isolated from plasma of cancer patients.

A second piece nests within a first piece and has a circumferential groove. A vent penetrates the first piece and matches the circumferential groove when the second piece is nested within the first piece. An o-ring is modified to allow equal pressure on either side of the o-ring.